MX2021014575A - Derivados heterociclicos condensados. - Google Patents
Derivados heterociclicos condensados.Info
- Publication number
- MX2021014575A MX2021014575A MX2021014575A MX2021014575A MX2021014575A MX 2021014575 A MX2021014575 A MX 2021014575A MX 2021014575 A MX2021014575 A MX 2021014575A MX 2021014575 A MX2021014575 A MX 2021014575A MX 2021014575 A MX2021014575 A MX 2021014575A
- Authority
- MX
- Mexico
- Prior art keywords
- fused heterocyclic
- heterocyclic derivatives
- compounds
- preparing
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La solicitud describe compuestos de derivado heterociclo condensado, composiciones farmacéuticas que comprenden estos compuestos, procedimientos químicos para preparar estos compuestos y su uso en el tratamiento de enfermedades asociadas con infección por VHB.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962853533P | 2019-05-28 | 2019-05-28 | |
EP19176933 | 2019-05-28 | ||
CN2020085720 | 2020-04-20 | ||
PCT/US2020/034643 WO2020243135A1 (en) | 2019-05-28 | 2020-05-27 | Fused heterocyclic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021014575A true MX2021014575A (es) | 2022-05-24 |
Family
ID=71741889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021014575A MX2021014575A (es) | 2019-05-28 | 2020-05-27 | Derivados heterociclicos condensados. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP3976617A1 (es) |
JP (1) | JP2022535734A (es) |
KR (1) | KR20220012913A (es) |
CN (1) | CN113906028A (es) |
AU (1) | AU2020285718A1 (es) |
BR (1) | BR112021022889A8 (es) |
CA (1) | CA3138168A1 (es) |
CL (1) | CL2021003155A1 (es) |
CO (1) | CO2021016433A2 (es) |
CR (1) | CR20210666A (es) |
IL (1) | IL288322A (es) |
JO (1) | JOP20210313A1 (es) |
MA (1) | MA56043A (es) |
MX (1) | MX2021014575A (es) |
PE (1) | PE20220767A1 (es) |
SG (1) | SG11202113167QA (es) |
WO (1) | WO2020243135A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022116999A1 (en) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives and their use in the treatment of hbv infection |
WO2022116998A1 (en) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives as hbv inhibitors |
WO2022116997A1 (en) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives and their use in the treatment of hbv infection |
WO2022253259A1 (en) | 2021-06-02 | 2022-12-08 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives |
UY39793A (es) * | 2021-06-02 | 2022-11-30 | Janssen Sciences Ireland Unlimited Co | Derivados heterocíclicos condensados |
WO2024114709A1 (en) * | 2022-12-01 | 2024-06-06 | Janssen Sciences Ireland Unlimited Company | A crystal form of a fused heterocycle derivative compound |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2993174A1 (en) * | 2014-09-08 | 2016-03-09 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Pyrazolopyridine derivatives and their use in therapy |
JP6713465B2 (ja) * | 2014-12-30 | 2020-06-24 | ノヴィラ・セラピューティクス・インコーポレイテッド | B型肝炎感染症治療のための誘導体及び方法 |
WO2018005883A1 (en) * | 2016-06-29 | 2018-01-04 | Novira Therapeutics, Inc. | Diazepinone derivatives and their use in the treatment of hepatitis b infections |
AU2017286890B2 (en) * | 2016-06-29 | 2021-09-09 | Novira Therapeutics, Inc. | Oxadiazepinone derivatives and their use in the treatment of hepatitis B infections |
-
2020
- 2020-05-27 SG SG11202113167QA patent/SG11202113167QA/en unknown
- 2020-05-27 KR KR1020217042210A patent/KR20220012913A/ko active Search and Examination
- 2020-05-27 CR CR20210666A patent/CR20210666A/es unknown
- 2020-05-27 WO PCT/US2020/034643 patent/WO2020243135A1/en active Application Filing
- 2020-05-27 PE PE2021001959A patent/PE20220767A1/es unknown
- 2020-05-27 AU AU2020285718A patent/AU2020285718A1/en active Pending
- 2020-05-27 CN CN202080039617.8A patent/CN113906028A/zh active Pending
- 2020-05-27 CA CA3138168A patent/CA3138168A1/en active Pending
- 2020-05-27 JP JP2021570274A patent/JP2022535734A/ja active Pending
- 2020-05-27 JO JOP/2021/0313A patent/JOP20210313A1/ar unknown
- 2020-05-27 MA MA056043A patent/MA56043A/fr unknown
- 2020-05-27 BR BR112021022889A patent/BR112021022889A8/pt unknown
- 2020-05-27 MX MX2021014575A patent/MX2021014575A/es unknown
- 2020-05-27 EP EP20744199.9A patent/EP3976617A1/en active Pending
-
2021
- 2021-11-23 IL IL288322A patent/IL288322A/en unknown
- 2021-11-26 CL CL2021003155A patent/CL2021003155A1/es unknown
- 2021-12-01 CO CONC2021/0016433A patent/CO2021016433A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN113906028A (zh) | 2022-01-07 |
CA3138168A1 (en) | 2020-12-03 |
BR112021022889A2 (pt) | 2022-01-04 |
JP2022535734A (ja) | 2022-08-10 |
MA56043A (fr) | 2022-04-06 |
CL2021003155A1 (es) | 2022-07-22 |
EP3976617A1 (en) | 2022-04-06 |
JOP20210313A1 (ar) | 2023-01-30 |
CO2021016433A2 (es) | 2021-12-10 |
AU2020285718A1 (en) | 2022-02-03 |
PE20220767A1 (es) | 2022-05-16 |
IL288322A (en) | 2022-01-01 |
WO2020243135A1 (en) | 2020-12-03 |
SG11202113167QA (en) | 2021-12-30 |
BR112021022889A8 (pt) | 2024-03-05 |
KR20220012913A (ko) | 2022-02-04 |
CR20210666A (es) | 2022-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021014575A (es) | Derivados heterociclicos condensados. | |
PH12019501034A1 (en) | New anthelmintic quinoline-3-carboxamide derivatives | |
PH12016501394A1 (en) | Compounds for treating patients with ros1 mutant cancer cells | |
PH12020500257A1 (en) | Quinoline derivatives for treating infections with helminths | |
PH12018550173A1 (en) | Pyrazolopyrimidine derivatives | |
PH12017502316A1 (en) | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | |
MX2022011029A (es) | Compuestos de arilo, heteroarilo y heterociclicos para el tratamiento de trastornos medicos. | |
PH12019502851A1 (en) | New azaquinoline derivatives | |
MY195002A (en) | Benzoxazepin oxazolidinone compounds and methods of use | |
MX2021007602A (es) | Derivados de heteroarildihidropirimidina y metodos de tratamiento de infecciones de hepatitis b. | |
PH12020551891A1 (en) | New quinoline derivatives | |
MX2019012803A (es) | Nuevos derivados de pirazol biciclicos. | |
IL286210A (en) | Compressed ring pyrimidine history for use in the treatment of hbv infection or diseases caused by hbv | |
WO2022116997A8 (en) | Fused heterocyclic derivatives and their use in the treatment of hbv infection | |
ZA202003281B (en) | Heterocycle substituted pyridine derivative antifungal agents | |
JOP20190086A1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
MX2021014576A (es) | Derivados heterociclicos condensados como agentes antivirales. | |
MX2018008153A (es) | Derivados de c-glicósido que tienen anillos de fenilo condensado o sales farmacéuticamente aceptables de los mismos, metodo para prepararlos y composición farmacéutica que los contiene. | |
ECSP21092791A (es) | Derivados heterocíclicos condensados | |
MX2021014581A (es) | Derivados heterociclicos condensados. | |
MX2022006489A (es) | Derivado de anillo de piridina fusionado, metodo de preparacion y usos farmaceuticos del mismo. | |
PH12021550572A1 (en) | Novel thiazole derivatives and pharmaceutically acceptable salts thereof | |
WO2018211323A8 (en) | Heterocyclic compounds for the treatment of disease | |
EA202193275A1 (ru) | Сочлененные гетероциклические производные | |
BR112018016208A2 (pt) | compostos heterocíclicos, em particular derivados 2-oxo-4,4,5,5,6,6,7,7-octahidrobenzoxazol, e seus usos como compostos antibacterianos |